Nifty 50 closed at 24,005.8, up 0.6% on the day, though it remains below its 200-day average and 8.8% off its 52-week high — the regime reads weak but recovering, now into a 21st consecutive day of that read, with the near-term tilt neutral-to-up. Advancers led decliners 1,207 to 1,012, and 182 stocks hit fresh 52-week highs against 66 new lows. Breadth is narrow but improving: 42% of stocks are above their 200-day average, 52.8% above their 50-day, and 56.2% above their 20-day — the short-end is doing the work. The Stage-2 advancing cohort now stands at 34.5% of the market, widening by roughly 1.5 over five days, 14 over 20 days, and 26 over 60 days — a steady, not dramatic, expansion.
Sector rotation: Real Estate holds the lead
Real Estate was the clear day leader at +3.1%, and it is also the top sector over one month (+9.7%) and second over three months (+23.1%) — a consistent thread in this recovery. Consumer Staples added 1.8% and Communication Services 1.5% on the day. Industrials, the three-month leader at +24.4%, continues to underpin the broader advance. Energy and Information Technology remain the three-month laggards at -5.6% and -1.0% respectively, though Aion-Tech Solutions, an IT name, was among the day's standout high-volume movers with a 17.9% gain on volume running nearly 13 times its norm — a single-stock event rather than a sector read. Health Care, Financials, and Materials are where the Stage-2 cohort is expanding fastest over the last 20 days, with Health Care carrying the highest Stage-2 participation rate at 46.8% of its stocks.
Standouts and screening results
Centrum Capital and Paisalo Digital, both in Financials, each rose 19.9% — Centrum on volume 37.7 times its average, Paisalo at 7.2 times. Om Freight Forwarders in Industrials gained 17.3% on volume 16.8 times normal. These cleared the high-volume mover screen but are single-session moves; the screener flags them for awareness, not as a pattern. On the breakout screen, Beta Drugs carries the highest setup score among today's fresh breakouts at 9.4, alongside Kirloskar Industries at 8.4 — both clearing the Stage-2 entry filter. Shriram Finance also appears in the breakout list at a setup score of 6.9, consistent with Financials being an area where the advancing cohort is broadening. Among sustained setups, Va Tech Wabag leads the sustained-setup screen at 9.6, with MSTC and IND Swift Laboratories also holding high scores. The five-day transition flow shows 66 stocks moving from Stage 1 to Stage 2 against 17 moving from Stage 2 to Stage 3 — a net of 49 stocks added to the advancing cohort this week, the most constructive internal reading of the session.
| Stock | Sector | Setup | % 1D |
|---|---|---|---|
| Beta Drugs Ltd | Health Care | 9.4 | +0.0% |
| Kirloskar Industries Ltd | Financials | 8.4 | +0.7% |
| Gufic Biosciences Ltd | Health Care | 7.4 | -3.1% |
| Premier Polyfilm Ltd | Consumer Discretionary | 7.3 | +1.9% |
| PPAP Automotive Ltd | Consumer Discretionary | 6.9 | +5.4% |
| Shriram Finance Ltd | Financials | 6.9 | +0.6% |
| Enviro Infra Engineers Ltd | Utilities | 6.3 | -0.9% |
| Suprajit Engineering Ltd | Consumer Discretionary | 5.5 | +1.2% |
| Sector | 1D | 1M | 3M | RS | Stage 2 |
|---|---|---|---|---|---|
| Real Estate | +3.1% | +9.7% | +23.1% | 41 | 16% |
| Consumer Staples | +1.8% | +3.6% | +8.2% | 55 | 36% |
| Communication Services | +1.5% | +4.0% | +14.3% | 59 | 19% |
| Financials | +0.8% | +7.2% | +6.2% | 60 | 35% |
| Energy | +0.8% | -0.7% | -5.6% | 53 | 36% |
| Consumer Discretionary | +0.6% | +4.9% | +12.5% | 65 | 32% |
| Industrials | +0.5% | +6.3% | +24.4% | 69 | 37% |
| Utilities | +0.4% | -0.2% | +8.9% | 64 | 34% |
| Materials | -0.2% | -2.3% | +10.4% | 68 | 39% |
| Health Care | -0.3% | +6.1% | +17.8% | 72 | 47% |
| Information Technology | -1.3% | -8.1% | -1.0% | 30 | 25% |
Stage2Stocks is an educational stage-analysis screener. These wraps describe what the screen shows across NSE cash equities — they are not investment advice, recommendations, or buy/sell calls. Always do your own research.
Nifty slips 0.5% but Stage-2 cohort keeps widening
Decliners dominated the tape; Health Care held firm and 81 stocks crossed into Stage 2 over five days.
Nifty flat, but Stage-2 cohort keeps widening — 80 fresh 1→2 transitions
Decliners outnumbered advancers 2:1, yet net new highs hit +80 and the advancing cohort added 3.3 names over 5 days.
Weekly: Nifty -0.5%; Stage-2 cohort adds 72 names
Index slipped but internals quietly strengthened — 80 stocks crossed from Stage 1 to Stage 2 this week.